| Recruiting | Evaluate the Safety and Immunogenicity After MG1111(BARICELA Inj.) as 2nd Vaccination in 4 ~ 6 Year Old Health Varicella | Phase 2 | 2022-07-05 |
| Completed | A Study to Assess Dose-Response, Efficacy (Immunogenicity) and the Safety of GC1109 Anthrax | Phase 2 | 2021-07-14 |
| Completed | COVIDIG (COVID-19 Hyper-ImmunoGlobulin) Covid19 | Phase 2 | 2020-09-19 |
| Completed | Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis: Autoimmune Encephalitis | Phase 2 | 2019-11-20 |
| Unknown | A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults Tetanus, Diphtheria, Whooping Cough | Phase 2 | 2019-10-14 |
| Completed | A Study of GC3107(BCG Vaccine) in Healthy Infants BCG Vaccination Reaction, Tuberculosis | Phase 3 | 2019-08-06 |
| Withdrawn | Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency Primary Immune Deficiency Disorder | Phase 3 | 2019-04-30 |
| Unknown | A Study of GC1102(Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients Hepatitis B | Phase 2 | 2019-02-11 |
| Completed | Study of Combined Therapy IVIG-SN 10% and Acetylsalicylic Acid in Kawasaki Disease Kawasaki Disease | Phase 4 | 2019-02-01 |
| Completed | A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patien Hemophilia | Phase 1 | 2019-01-21 |
| Completed | A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects Influenza, Human | Phase 2 | 2018-10-01 |
| Completed | A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy Metastatic Colorectal Cancer, Solid Tumor | Phase 1 / Phase 2 | 2018-04-02 |
| Unknown | HBV-associated Liver Transplant(LT) Patients by IV Injecting GC1102 Hepatitis B Infection | Phase 2 / Phase 3 | 2018-03-29 |
| Unknown | Study to Investigate the Safety and Efficacy of GC3107 (BCG Vaccine) in Healthy Adults Tuberculosis | Phase 1 | 2017-12-14 |
| Completed | A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults Influenza, Human | Phase 1 | 2017-11-20 |
| Unknown | A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Infants From 6 Months to 35 Months of Age Influenza Vaccine | Phase 3 | 2017-09-30 |
| Completed | A Study of GC1111 in Hunter Syndrom Patients Hunter Syndrome | Phase 3 | 2017-03-09 |
| Unknown | Study of Idursulfase-beta (GC1111) in Hunter Syndrome Mucopolysaccharidosis II | Phase 2 | 2016-12-01 |
| Completed | A Study of MG1111 in Healthy Children Healthy Children | Phase 2 / Phase 3 | 2016-11-26 |
| Completed | A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older Influenza, Human | Phase 3 | 2016-10-10 |
| Unknown | A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults Influenza, Human | Phase 3 | 2016-10-01 |
| Completed | Study of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency Immunologic Deficiency Syndromes | Phase 3 | 2016-10-01 |
| Unknown | Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine Tetanus, Diphtheria, Whooping Cough | Phase 1 / Phase 2 | 2016-06-01 |
| Completed | A Phase 1 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in Chronic Hepatitis B Patients Chronic Hepatitis B | Phase 1 | 2015-11-09 |
| Unknown | Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult Healthy | Phase 3 | 2015-11-01 |
| Unknown | A Multicenter, Double-blind, Parallel, Non-inferiority, Phase III Study Influenza | Phase 3 | 2015-11-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of 'GC3110A(QIV)' in Healthy Children Influenza | Phase 3 | 2015-09-01 |
| Completed | Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults Varicella (Chicken Pox) | Phase 1 | 2015-03-01 |
| Completed | A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients Hepatitis B Infection | Phase 2 | 2015-02-01 |
| Unknown | Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer Neoplasm Metastasis, Gastric Cancer, Colorectal Cancer | Phase 1 | 2015-01-01 |
| Completed | Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine) Influenza | Phase 1 / Phase 2 | 2014-10-01 |
| Completed | A Multicenter, Double-blind, Parallel Phase III Study Influenza | Phase 3 | 2014-10-01 |
| Unknown | Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis Gastritis | Phase 2 | 2014-09-01 |
| Completed | An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia Immune Thrombocytopenia | Phase 3 | 2014-06-01 |
| Completed | A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine) Influenza | Phase 1 / Phase 2 | 2014-05-01 |
| Completed | To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Bacterial Infections | Phase 3 | 2014-05-01 |
| Unknown | A Prospective Observational Study on Discontinuation of Medication of Shinbaro Capsule Osteoarthritis | — | 2014-05-01 |
| Unknown | The Long-term Safety Study of Idursulfase-beta in Hunter Syndrome(Mucopolysaccharidosis II) Patients Hunter Syndrome | — | 2014-01-01 |
| Unknown | Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemop Hemophilia A | Phase 3 | 2014-01-01 |
| Completed | A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered G Healthy Volunteers | Phase 1 | 2013-08-01 |
| Completed | Phase III Study to Evaluate the Immunogenicity and Safety of MG1109 in Healthy Adult Volunteers Influenza | Phase 3 | 2013-08-01 |
| Completed | To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC3102C' Administered Intramuscularly in Healthy Prophylaxis Against Influenza | Phase 3 | 2013-06-01 |
| Unknown | Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A Hemophilia A | Phase 3 | 2013-03-01 |
| Completed | Study for Hyalobarrier to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG After Thyroidectomy Thyroid Disease | Phase 3 | 2012-12-01 |
| Completed | Evaluate the Safety and Exploratory Efficacy of GC1119 Fabry Disease | Phase 1 | 2012-11-01 |
| Completed | Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Inje Hepatitis B | Phase 1 | 2012-08-01 |
| Completed | Safety and Efficacy of Hunterase Hunter Syndrome | Phase 3 | 2012-07-01 |
| Completed | To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis Osteoarthritis | Phase 4 | 2012-05-01 |
| Completed | A Study to Assess Safety, Tolerability, and Pharmacokinetics of Orally Administered GCC4401C in Healthy Volunt Healthy Male | Phase 1 | 2012-03-01 |
| Completed | Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease Kawasaki Disease | Phase 4 | 2012-01-01 |
| Completed | Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency Immunologic Deficiency Syndrome | Phase 3 | 2011-09-01 |
| Completed | To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy C Bacterial Infections | Phase 2 / Phase 3 | 2011-08-01 |
| Completed | To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin Healthy Volunteer | Phase 1 | 2011-06-01 |
| Terminated | Safety Study of MG1102 in Patients With Solid Tumors Solid Tumors | Phase 1 | 2010-11-01 |
| Completed | GCPGC in Chemotherapy-induced Neutropenia Chemotherapy Induced Neutropenia | Phase 2 / Phase 3 | 2010-10-01 |
| Completed | Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC Prevention of Influenza | Phase 4 | 2010-10-01 |
| Completed | To Evaluate the Safety and Efficacy of GC1111 (Recombinant Human Iduronate-2-sulfatase) in Hunter Syndrome Pat Mucopolysaccharidosis II | Phase 1 / Phase 2 | 2010-05-01 |
| Completed | Study to Evaluate the Safety and Immunogenicity of MG1109 in Healthy Adult Volunteers Influenza | Phase 1 / Phase 2 | 2010-02-01 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine Influenza Infection | Phase 3 | 2009-10-01 |
| Terminated | GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock Severe Sepsis, Septic Shock | Phase 3 | 2009-10-01 |
| Completed | Efficacy and Safety of Shinbaro Capsule Osteoarthritis | Phase 3 | 2009-05-01 |
| Completed | Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS Infection | Phase 3 | 2007-12-01 |
| Completed | Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A Hemophilia A | Phase 3 | 2004-12-01 |